Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of artesunate-amodiaquine combined with either methylene blue or primaquine in children with falciparum malaria in Burkina Faso: A randomized controlled trial

Published:2019-10-10 Issue:10 Volume:14 Page:e0222993
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mendes Jorge Margarida^ORCID,Ouermi Lucienne^ORCID,Meissner Peter^ORCID,Compaoré Guillaume,Coulibaly Boubacar,Nebie Eric,Krisam Johannes^ORCID,Klose Christina,Kieser Meinhard^ORCID,Jahn Albrecht,Lu Guangyu,D`Alessandro Umberto^ORCID,Sié Ali,Mockenhaupt Frank Peter,Müller Olaf

Funder

BASF

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Malaria.;BM Greenwood;Lancet,2005

2. WHO. World Malaria report 2017. 2017.

3. Malaria in Africa: Challenges for control and elimination in the 21st Century: Peter Lang Verlag, Frankfurt;O Müller,2011

4. Clinical efficacy of chloroquine in young children with uncomplicated falciparum malaria—a community-based study in rural Burkina Faso. Tropical Medicine &;O Müller;International Health,2003

5. Malaria.;EA Ashley;The Lancet,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso;Antimicrobial Agents and Chemotherapy;2024-04-03

2. The activity of methylene blue against asexual and sexual stages of Plasmodium vivax;Frontiers in Cellular and Infection Microbiology;2023-04-18

3. Antimalarial drugs;Medicinal Chemistry of Chemotherapeutic Agents;2023

4. Clinical effectiveness and prospects of methylene blue: A systematic review;Precision and Future Medicine;2022-12-31

5. Rapid and Specific Action of Methylene Blue against Plasmodium Transmission Stages;Pharmaceutics;2022-12-14